Abstract
High-dose aprotinin administration in open-heart surgery has been proved to offer a major reduction in the need for donor blood [1, 2, 10]. We have performed several studies that all revealed a decrease of homologous blood requirement by 7 5%[4, 5].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bidstrup BP, Royston D, Sapsford RN, Taylor KM (1989) Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 97: 364–372
Dietrich W, Barankay A, Dilthey G, Henze R, Niekau E, Sebening F, Richter JA (1989) Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application — Clinical experience in 152 cardiac surgical patients. Thorac Cardiovasc Surgeon 37: 92–98
Edmunds LH, Addonizio VP (1987) Extracorporeal circulation. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and thrombosis — Basic principles and clinical practice. JB Lippincott Co, Philadelphia, pp 901–912
Fraedrich G, Weber C, Bernard C, Hettwer A, Schlosser V (1989) Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin — Preliminary results. Thorac Cardiovasc Surgeon 37: 89–91
Fraedrich G, Engler H, Weber C, Schlosser V (1990) Effect and potential mechanism of high dose aprotinin regimen in open heart surgery — a prospective randomised double blind trial. In: Birnbaum D, Hoffmeister HE (eds) Blood saving in open heart surgery. Schattauer, Stuttgart—New York, in press
Freeman JG, Turner GA, Venables CW, Latner AL (1983) Serial use of aprotinin and incidence of allergic reactions. Curr Med Res Opin 8: 559–561
Frith H, Wunderer G, Jochum M (1983) Biochemie und Anwendung des Kallikreininhibitors Aprotinin aus Rinderorganen. Arzneim Forsch Drug Res 33: 479–494
Hofmann W, Guder WG (1989) A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 27: in press
Sunamori M, Innami R, Amano J, Suzuki A, Harrison CE (1988) Role of protease inhibition in myocardial preservation in prolonged hypothermic cardioplegia followed by reperfusion. J Thorac Cardiovasc Surg 96: 414–320
van Oeveren W, Jansen NJ, Bidstrup BP, Royston D, Westaby S, Neuhof H (1987) Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 44: 640–645
Weiss ME, Adkinson NF, Hirshman CA (1989) Evaluation of allergic drug reactions in the perioperative period. Anesthesiology 71: 483–486
Yanagihara Y, Shida T (1985) Immunological studies on patients who received aprotinin therapy. Jpn J Allergol 34: 899–904
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Fraedrich, G. et al. (1991). Safety and Risk/Benefit Assessment of Aprotinin in Primary CABG. In: Friedel, N., Hetzer, R., Royston, D. (eds) Blood Use in Cardiac Surgery. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-06119-0_36
Download citation
DOI: https://doi.org/10.1007/978-3-662-06119-0_36
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-662-06121-3
Online ISBN: 978-3-662-06119-0
eBook Packages: Springer Book Archive